X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with Cipla - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs CIPLA - Comparison Results

CIPLA 
   Change

Cipla is one of the largest pharma companies in the domestic market and has presence in formulations and bulk drugs manufacturing. All the bulk drug manufacturing facilities of the company have been approved by various authorities including the US FD... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. CIPLA FDC LTD./
CIPLA
 
P/E (TTM) x 17.2 43.7 39.3% View Chart
P/BV x 3.6 3.6 99.5% View Chart
Dividend Yield % 1.3 0.4 370.5%  

Financials

 FDC LTD.   CIPLA
EQUITY SHARE DATA
    FDC LTD.
Mar-14
CIPLA
Mar-17
FDC LTD./
CIPLA
5-Yr Chart
Click to enlarge
High Rs144622 23.1%   
Low Rs79458 17.2%   
Sales per share (Unadj.) Rs47.6181.9 26.2%  
Earnings per share (Unadj.) Rs7.612.9 59.1%  
Cash flow per share (Unadj.) Rs9.029.3 30.7%  
Dividends per share (Unadj.) Rs2.252.00 112.5%  
Dividend yield (eoy) %2.00.4 546.2%  
Book value per share (Unadj.) Rs47.5155.7 30.5%  
Shares outstanding (eoy) m177.83804.51 22.1%   
Bonus/Rights/Conversions BBESOP-  
Price / Sales ratio x2.33.0 78.8%   
Avg P/E ratio x14.642.0 34.8%  
P/CF ratio (eoy) x12.318.4 67.0%  
Price / Book Value ratio x2.33.5 67.5%  
Dividend payout %29.615.5 190.3%   
Avg Mkt Cap Rs m19,784434,516 4.6%   
No. of employees `000NA23.0 0.0%   
Total wages/salary Rs m1,22126,338 4.6%   
Avg. sales/employee Rs ThNM6,349.1-  
Avg. wages/employee Rs ThNM1,143.0-  
Avg. net profit/employee Rs ThNM449.3-  
INCOME DATA
Net Sales Rs m8,459146,302 5.8%  
Other income Rs m3942,287 17.2%   
Total revenues Rs m8,852148,589 6.0%   
Gross profit Rs m2,07024,758 8.4%  
Depreciation Rs m24913,229 1.9%   
Interest Rs m311,594 1.9%   
Profit before tax Rs m2,18412,222 17.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m-225-70 321.7%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6061,798 33.7%   
Profit after tax Rs m1,35310,354 13.1%  
Gross profit margin %24.516.9 144.6%  
Effective tax rate %27.714.7 188.5%   
Net profit margin %16.07.1 226.0%  
BALANCE SHEET DATA
Current assets Rs m4,35587,370 5.0%   
Current liabilities Rs m1,79233,081 5.4%   
Net working cap to sales %30.337.1 81.7%  
Current ratio x2.42.6 92.0%  
Inventory Days Days4487 51.1%  
Debtors Days Days2562 39.6%  
Net fixed assets Rs m3,025111,567 2.7%   
Share capital Rs m1791,609 11.1%   
"Free" reserves Rs m8,243123,645 6.7%   
Net worth Rs m8,453125,254 6.7%   
Long term debt Rs m1136,454 0.0%   
Total assets Rs m10,557209,532 5.0%  
Interest coverage x71.48.7 823.9%   
Debt to equity ratio x00.3 0.4%  
Sales to assets ratio x0.80.7 114.7%   
Return on assets %13.15.7 229.9%  
Return on equity %16.08.3 193.6%  
Return on capital %23.58.5 276.6%  
Exports to sales %13.334.2 38.9%   
Imports to sales %3.38.3 40.1%   
Exports (fob) Rs m1,12650,050 2.2%   
Imports (cif) Rs m28312,203 2.3%   
Fx inflow Rs m1,14651,066 2.2%   
Fx outflow Rs m35517,678 2.0%   
Net fx Rs m79133,388 2.4%   
CASH FLOW
From Operations Rs m1,48523,824 6.2%  
From Investments Rs m-620-13,127 4.7%  
From Financial Activity Rs m-753-13,239 5.7%  
Net Cashflow Rs m113-2,478 -4.6%  

Share Holding

Indian Promoters % 68.9 16.0 430.6%  
Foreign collaborators % 0.0 20.8 -  
Indian inst/Mut Fund % 4.7 12.2 38.5%  
FIIs % 7.5 23.7 31.6%  
ADR/GDR % 0.0 1.1 -  
Free float % 19.0 26.2 72.5%  
Shareholders   23,730 161,166 14.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   AUROBINDO PHARMA  MERCK LTD  NOVARTIS  J.B.CHEMICALS  ORCHID PHARMA LTD  

Compare FDC LTD. With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Post Noon Sell-Off; Infosys Falls 5.4%(Closing)

Share markets in India witnessed a sharp fall in the final minutes of trade. At the closing bell, the BSE Sensex closed lower by 266 points. While, the NSE Nifty finished lower by 83 points.

Related Views on News

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Cipla: Weak Quarter, Positive Triggers Ahead (Quarterly Results Update - Detailed)

Sep 19, 2016

Cipla has announced its results for the June quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Aug 21, 2017 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE FDC LTD. WITH

MARKET STATS